ʻO ka nasal cannula kahi lāʻau lapaʻau e hāʻawi i ka oxygen i ka ihu. He maʻalahi kona hoʻolālā e hoʻomaʻemaʻe a lōʻihi ke ola inā mālama pono ʻia. Hoʻohana ʻia nā cannulas nasal e hāʻawi i ka oxygen ke koi ʻia kahi kahe haʻahaʻa, haʻahaʻa a haʻahaʻa paha, a aia ka mea maʻi i kahi kūlana paʻa. Hoʻohana ka nasal cannulas i ka oxygenation kiʻekiʻe a me kahi humidifier e hāʻawi i ka mea maʻi me ka oxygen.
ʻO ke kahe kiʻekiʻe o nā cannulas e paʻi i ke kūʻē ʻana mai ke kahe ʻana, e hoʻonui ai i ke kaomi ea. ʻIke ʻia kēia piʻi ʻana o ke kaomi ea ma ke ʻano neonate me ka ʻole o ka puʻupuʻu palena ʻole. No ka pale ʻana i ka maʻi, pono e hoʻomaʻemaʻe nā mea maʻi i ka paipu cannula ma mua o ka hoʻohana ʻana. No ka hoʻomaʻemaʻe ʻana i ka cannula a ʻaʻohe bacteria, pono e hoʻomaʻemaʻe ʻia me ka vīneka keʻokeʻo a me ka wai mahana. Hoʻopau ka vīneka i ka maʻi bacteria akā ʻaʻole ʻai i ka mea paipu. A laila, pono e holoi ʻia ka cannula me ka wai anuanu e wehe i ke kopa a me ka bacteria. A laila, pono e hoʻomaloʻo ʻia ka cannula ma mua o ka hoʻohana ʻana. He mea nui ka hoʻololi ʻana i nā cannulas no nā maʻi e loaʻa ana i nā maʻi hanu.
Nā Keaukaha Makeke:
Manaʻo ka piʻi nui o ka hānō e hoʻoulu i ka ulu ʻana o ka mākeke cannula nasal honua i ka wā wānana. No ka laʻana, e like me ka The Global Asthma Report 2018, ʻo ka prevalence o nā hōʻailona hānō he 23% a me ka prevalence o kahi hōʻailona olakino o ka hānō 12% ma Brazil.
Nā Kūpono Mākeke:
Manaʻo ka hoʻonui ʻana i ka hiki ke hāʻawi i nā manawa ulu ulu no nā mea pāʻani i ka mākeke cannula nasal honua. No ka laʻana, i ka mahina ʻo Iune 2020, ua hoʻonui ʻo Vapotherm, Inc. i kāna mau mea hana pono hana e hiki ai i ka hui ke hoʻonui i ka hana o kāna ʻōnaehana Precision Flow a hiki i ka 20X ma luna o nā pae maʻi maʻi pre-COVID-19.
Nā Hōʻai'ē Kūʻai:
Manaʻo ʻia ʻo ʻAmelika ʻAmelika e ʻike i ka ulu nui o ka mākeke cannula nasal honua, ma muli o ka piʻi nui o nā maʻi reparatory maʻi. No ka laʻana, e like me Globocan 2018, Brazil hoʻopaʻa 'ia 559, 371 hou hihia o ka maʻi maʻi 'aʻai ma 2018. E like me ka haʻawina 'Chronic Obstructive Pulmonary maʻi ma Latin America', i paʻi ma Ianuali 2019 i loko o ka puke pai Annals o Global Health, ka prevalence o ʻO ka COPD ma nā kūlanakauhale ʻo ʻAmelika Latina ma waena o 6.2 a me 19.6% i nā poʻe ma mua o 40 mau makahiki a keu.
ʻO ka ulu ʻana o Covid-19 ua alakaʻi i ka hoʻonui ʻana i ka hoʻohana ʻana i ka cannula nasal. Ma ke ao holoʻokoʻa, ma ka hola 5:14pm CET, 17 Dekemaba 2021, aia he 271,963,258 mau hihia i hoʻopaʻa ʻia o COVID-19, me 5,331,019 mau make, i hōʻike ʻia iā WHO. Ma ka lā 16 Dekemaba 2021, he 8,337,664,456 ka nui o nā kano kano i hāʻawi ʻia.
Landskap hoʻokūkū:
ʻO nā mea pāʻani nui e hana ana i ka mākeke cannula nasal honua, ʻo Allied Healthcare Products, Besmed Health Business Corp., Drive Devilbiss International, Edward LifeSciences Corp., Fairmont Medical, Flexicare Medical, Medtronic plc., Maquet Holding BV & Co. KG , Medin Medical Nā Innovations, Salter Labs, Sorin Group, Smiths Medical, Terumo Corporation, Teleflex Incorporated, Vapotherm Inc., a me Well Lead Medical Co. Ltd.